8.48
2.05%
0.17
Dopo l'orario di chiusura:
8.48
Precedente Chiudi:
$8.31
Aprire:
$8.18
Volume 24 ore:
175.54K
Relative Volume:
0.94
Capitalizzazione di mercato:
$201.98M
Reddito:
$315.66M
Utile/perdita netta:
$-102.45M
Rapporto P/E:
-2.0239
EPS:
-4.19
Flusso di cassa netto:
$-30.25M
1 W Prestazione:
-5.36%
1M Prestazione:
-10.36%
6M Prestazione:
+7.89%
1 anno Prestazione:
+45.96%
Inogen Inc Stock (INGN) Company Profile
Nome
Inogen Inc
Settore
Industria
Telefono
805-562-0500
Indirizzo
859 WARD DRIVE, GOLETA, CA
Confronta INGN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
INGN
Inogen Inc
|
8.48 | 201.98M | 315.66M | -102.45M | -30.25M | -4.41 |
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-02-15 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2023-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
2023-07-14 | Downgrade | Needham | Buy → Hold |
2023-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
2021-12-09 | Aggiornamento | Needham | Hold → Buy |
2021-11-02 | Aggiornamento | JP Morgan | Underweight → Neutral |
2021-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2021-06-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2020-12-14 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-07-23 | Downgrade | Needham | Buy → Hold |
2020-05-06 | Reiterato | Needham | Buy |
2019-11-06 | Aggiornamento | Needham | Hold → Buy |
2019-09-13 | Reiterato | Piper Jaffray | Overweight |
2019-08-08 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2019-08-08 | Downgrade | Stifel | Buy → Hold |
2019-08-07 | Downgrade | Needham | Buy → Hold |
2019-06-28 | Downgrade | Needham | Strong Buy → Buy |
2019-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
2019-05-08 | Reiterato | Needham | Strong Buy |
2019-02-27 | Reiterato | Needham | Strong Buy |
2018-11-20 | Aggiornamento | Needham | Buy → Strong Buy |
2018-11-07 | Reiterato | Needham | Buy |
2018-09-10 | Downgrade | Needham | Strong Buy → Buy |
2018-08-22 | Ripresa | Stifel | Buy |
2018-08-08 | Reiterato | Needham | Strong Buy |
2018-06-06 | Iniziato | KeyBanc Capital Mkts | Sector Weight |
2018-05-01 | Reiterato | Needham | Strong Buy |
2018-02-28 | Reiterato | Needham | Strong Buy |
Mostra tutto
Inogen Inc Borsa (INGN) Ultime notizie
Inogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78% - Yahoo Finance
StockNews.com Downgrades Inogen (NASDAQ:INGN) to Hold - MarketBeat
Inogen, Inc.'s (NASDAQ:INGN) institutional investors lost 12% over the past week but have profited from longer-term gains - Simply Wall St
Short Interest in Inogen, Inc. (NASDAQ:INGN) Grows By 6.7% - MarketBeat
BNP Paribas Financial Markets Increases Stock Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (NASDAQ:INGN) Raised to Buy at StockNews.com - Defense World
Respiratory Care Market Set to Witness Significant Growth by 2024-2031:Inogen, Inc., Honeywell International - EIN News
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Yahoo Finance
Oxygen Concentrators Global Market Report: Market - openPR
Inogen Alliance Releases 2023 ESG Report - AccessWire
Respiratory Care Market Projected To Witness Substantial Growth, 2024-2031: Inogen, Inc., Honeywell - EIN News
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
INGN (Inogen) Earnings per Share (Diluted) : $-2.25 (TTM As of Sep. 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Buys 132,287 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Inogen (NASDAQ:INGN) Stock Rating Lowered by StockNews.com - Defense World
Brown Capital Management LLC Reduces Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - MSN
Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say - MSN
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up - MSN
Short Interest in Inogen, Inc. (NASDAQ:INGN) Decreases By 11.4% - MarketBeat
Inogen, Inc. (NASDAQ:INGN) Q3 2024 Earnings Call Transcript - Insider Monkey
US$10.00That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results - Yahoo Finance
Inogen (NASDAQ:INGN) soars 28% this week, taking one-year gains to 129% - Simply Wall St
Inogen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Inogen Inc (INGN) Quarterly 10-Q Report - Quartzy
Inogen (NASDAQ:INGN) Earns "Hold" Rating from Needham & Company LLC - MarketBeat
Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates - MSN
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B G - GuruFocus.com
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges By GuruFocus - Investing.com Canada
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges - Yahoo Finance Australia
Inogen, Inc. Reports Third Quarter 2024 Financial Results - TipRanks
Inogen Inc earnings beat by $0.25, revenue topped estimates - Investing.com Canada
Inogen: Q3 Earnings Snapshot - San Antonio Express-News
Inogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Inogen Announces Third Quarter 2024 Financial Results - The Bakersfield Californian
Sight Sciences Strengthens Leadership: Ophthalmic Innovation Expert & Inogen Co-Founder Join Executive Team | SGHT Stock News - StockTitan
Inogen, Inc. (INGN): A Bear Case Theory - Insider Monkey
Inogen Q3 Revenue Jumps 5.8% to $88.8M as Margins Surge; Turns EBITDA Positive - StockTitan
Inogen Inc (INGN) Q3 2024 Earnings Report Preview: What To Expec - GuruFocus.com
Inogen Inc (INGN) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Respiratory Care Market Projected To Witness Substantial Growth, 2024-2031: TytoCare Ltd., Inogen, Inc., - EIN News
Inogen to Present at Upcoming Investor Conferences - sharewise
9 Best Portable Oxygen Concentrators in November 2024: Our Expert Picks - National Council on Aging
INGNInogen Inc Latest Stock News & Market Updates - StockTitan
Inogen (NASDAQ:INGN) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Inogen (INGN) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Inogen Debuts Rove 4 Portable Oxygen Concentrator - MPO-mag
Inogen (NASDAQ:INGN) Stock Price Crosses Below 200 Day Moving AverageHere's What Happened - MarketBeat
Inogen Inc Azioni (INGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inogen Inc Azioni (INGN) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):